Cellectis
| Use attributes for filter ! | |
| Stock price | ALCLS |
|---|---|
| Disclaimer | |
| Headquarters | France |
| Founders | André Choulika |
| Founded | 1999 |
| Key person | André Choulika |
| Subsidiaries | Calyxt |
| Cellectis stem cells | |
| Cellectis, Inc | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1165235 |
About Cellectis
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, France, New York, New York and Raleigh, North Carolina.
